Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats
The pharmacokinetic variability of nifedipine widely observed in the clinic cannot be fully explained by pharmacogenomics. As a new factor affecting drug metabolism, how the gut microbiota affects the pharmacokinetics of nifedipine needs to be explored. Spontaneously hypertensive rats (SHRs) have be...
Saved in:
Main Authors: | Rong Zhou (Author), Haijun Yang (Author), Peng Zhu (Author), Yujie Liu (Author), Yanjuan Zhang (Author), Wei Zhang (Author), Honghao Zhou (Author), Xiong Li (Author), Qing Li (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the multiple effects of nifedipine and captopril administration in spontaneously hypertensive rats through pharmacokinetic‐pharmacodynamic analyses
by: Akiko Kiriyama, et al.
Published: (2024) -
Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin
by: Jin-Bo Yu, et al.
Published: (2019) -
The Role of Gut Microbiota in Atherosclerosis and Hypertension
by: Junli Ma, et al.
Published: (2018) -
The Combination of Scutellaria baicalensis Georgi and Sophora japonica L. ameliorate Renal Function by Regulating Gut Microbiota in Spontaneously Hypertensive Rats
by: Yiqing Guan, et al.
Published: (2021) -
Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
by: Zhen Xiong Zhao, et al.
Published: (2022)